Thank you, Sue. As many of you know, the external environment during Q1 became increasingly complex, with highly volatile FOREX rates and further uncertainty regarding the future interest rate environment globally. Despite this dynamic backdrop, I am pleased to share our results, as we continued to show solid progress across key financial KPIs including gross margin, profit, and deleveraging. The virtuous cycle is fully in motion, and delivering the results we set out to achieve. I am also very encouraged by the interactions and engagement we have had with many of you in the investment community, during the quarter. The progress we have made is increasingly being recognized, particularly as long-only institutions now account for a significant majority of Coty's public ownership, and there is a heightened awareness of Coty being an attractive and sustainable investment. Let’s start with our gross margin performance in the quarter. Q1 adjusted gross margin of 64.1% increased 70 basis points from last year. Gross margin performance in the quarter was driven primarily by strong price improvement in both Prestige and Consumer Beauty, as well as improvements in trade spend. While we see mix as one of the positive building blocks in our gross margin expansion going forward, this quarter the mix benefit was limited based on the growth dynamics in both divisions and the outsized contribution from body care, which Sue alluded to earlier. The positive drivers more than offset the heightened level of COGS inflation, which were approximately 200 basis points of revenues, similar to what we experienced in Q4. Given the significant volatility in FOREX rates more recently, and particularly the Euro and Pound, I want to briefly discuss the natural hedge in our business model. The deterioration in both of these currencies has had a material impact on our reported sales, with a 7% negative FOREX impact at the top-line. However, the majority of our manufacturing and sourcing takes place in Europe, including some in the UK. This creates some natural hedge in our business, limiting the FOREX exposure on our gross margin. Going forward, we will continue to execute on our multi-pronged, multi-year gross margin attack plan, and we remain well-positioned to benefit from positive mix shifts in the business. Now let’s touch on the global supply and inflationary backdrop, and how we are navigating through this challenging environment. As Sue alluded to earlier, global supply chain complexities coupled with ongoing robust demand for fragrances, which was not fully anticipated by the supply chain, is driving industry-wide supply constraints in key fragrance components. Several of our peers have discussed the shortages in key components like glass bottles, and to a lesser extent, caps and pumps. As a result, with fragrance volumes ramping up seasonally in Q1, our service levels remained in the low 90s for Consumer Beauty, but slipped below 80% for Prestige. The feedback we have received from our retailers suggests that our peer set is experiencing similar dynamics. And with seasonally stronger fragrance demand in Q2, we are expecting similar constraints for this coming quarter. The issue ultimately traces back to the general elevated lead-times and raw material constraints across the global supply chain, which is impacting the supply to our own suppliers, and exacerbated further by a fragrance market which shows no sign of slowing, which has depleted the safety stock in the supply chain. As a company, we are preparing ourselves for this economy of scarcity, building crucial inventory when available and shifting support behind lines where stock is available. Ultimately, this supply/demand imbalance is a good problem to have in the current environment, and only reinforces our pricing power as we look to take an additional round of mid single-digit pricing in late winter, following the mid single-digit pricing we executed this past quarter. It is also important to stress that despite these component constraints, we delivered Q1 revenues ahead of guidance and strong gross margin expansion in the quarter. We’re also cognizant of investor concerns about energy supply in Europe and our manufacturing base there. Here, we have developed business continuity plans and dual sourcing initiatives, to protect our inputs. At the same time, due to the low energy usage in our own manufacturing plants, we see limited risk of an energy-related business disruption. And finally, on inflation, our gross margin outlook remains unchanged as we continue to estimate COGS inflation of approximately 2% of revenues in FY 2023, to be offset by pricing, mix benefits, and savings. Let me now provide an update on our All-in-to-Win program. In Q1, we delivered savings of over $20 million, driven by a combination of fixed cost and gross margin initiatives. And based on the clear stream of projects ramping up over the course of the year, we continue to expect total FY 2023 savings of $170 million. The projects that we expect to ramp up and contribute more significantly in Q2 through Q4 include: material value analysis, as we continue to streamline sourcing and variability in non-value-added components. Optimization in trade spend and A&CP. Improvement in excess & obsolescence charges, as we continue to improve our forecasting and planning processes. Now moving to a recap of our marketing investments. During Q1, A&CP investments represented over 24% of sales, which is down slightly from last year. Importantly, our working media at constant currency grew year-on-year and was relatively stable as a percentage of sales. We targeted our media investments behind our most recent and successful innovations including the new Burberry Hero EDP, Gucci Flora Gorgeous Jasmine, Hugo Boss Bottled Parfum in Prestige as well as CoverGirl Simply Ageless innovation bundle and Rimmel Thrillseeker mascara in Consumer Beauty. We also continued investment behind our whitespace areas of Prestige makeup and skincare. Now, with Q2 underway, we expect a meaningful ramp-up in our A&CP spending during this critical sell-out period. And for the full fiscal 2023, we continue to expect our A&CP investments to be in the high-20% level of sales. Now moving to our profit delivery for the quarter. Our Q1 adjusted operating income grew a robust 24% to $250 million, driving a 340 basis point improvement in our adjusted operating margin to 18%. Importantly, both divisions delivered over 300 basis points of operating margin Improvement. On adjusted EBITDA, we delivered 11% growth to $308 million. As a result, our adjusted EBITDA margin was 22.2%, or up 190 basis points versus last year. Our profit improvement in the quarter was driven by our solid revenue growth, gross margin expansion, fixed cost leverage, as well as the slight decline in A&CP. Now moving to our adjusted EPS, which includes the following drivers. Adjusted EBITDA in Q1 of $308 million, depreciation of $58 million, net interest of $66 million, income tax of $44 million, representing an adjusted effective tax rate of 29.6%; and diluted share count of 859 million. As a result, our Q1 diluted adjusted EPS was $0.11, an improvement of $0.03 versus last year. It is important to highlight that this adjusted EPS of $0.11 included a negative impact of $0.04 from the equity swap. Recall, we previously entered into a total return swap transaction with several bank counterparties, effectively locking in an attractive share price below $7.50 for a targeted $200 million share buyback program during calendar 2024. Beginning in Q1, the non-cash, mechanical mark-to-market on this total return swap has to be included in our adjusted net income and EPS calculation, flowing into the other income line. These mark-to-market EPS impacts will continue to factor into our net income and EPS calculations moving forward. Looking ahead to Q2 and FY 2023, let me provide some additional details related to our current expectations for certain drivers of our adjusted EPS. First, we continue to expect depreciation to be in the mid $200 million. Second, we continue to expect net interest for the year to also be in the mid $200 million, reflecting the fact that the majority of our debt is fixed and we have hedging in place on most of the remainder. Third, we continue to expect an adjusted effective tax rate for fiscal 2023 in the high 20%, assuming no significant changes in tax regulations; and finally on FY 2023 share count, based on the GAAP accounting provisions around anti-dilution, we now expect diluted shares consistent with Q1 at $860 million to $870 million. Moving to our free cash flow. We generated $88 million of free cash flow in the quarter, consistent with our expectations. The quarterly results reflected the timing of certain CapEx and working capital payments, as well as the increase in inventory as we build stock in certain components as part of our efforts to mitigate the global component shortages we discussed earlier. For the full year, we continue to expect strong free cash flow generation, though as we indicated on the last call, we would expect the cash flow to be a little lower than FY 2022 due to one-time working capital benefits which helped FY 2022 and won’t repeat in FY 2023. Our intent is to continue to use our strong free cash flow to steadily reduce our debt and advance our deleveraging agenda. Moving to our capital structure. We ended Q1 with net debt of just under $4.2 billion, an improvement of roughly $100 million from Q4, driven by our free cash flow. As a result, our leverage at the end of the quarter was below 4.5 times, down from 4.7 times at the end of Q4. And with Q2 as our seasonally strongest free cash flow quarter, we remain fully on-track to bring our leverage down towards four times by the end of calendar 2022. In the quarter, the book value of our 26% stake in Wella increased to approximately $1billion, reflecting Wella’s acquisition of a high-growth haircare brand. Factoring in our Wella stake, we ended the quarter with economic net debt of approximately $3.2 billion. I would also like to take a minute to address the rising, and seemingly uncertain, interest rate environment and Coty’s sensitivity to this. Approximately two third of our debt is fixed rate notes, and for the remaining variable debt, we have hedging in place, such that 90% of our debt is fixed, supporting our unchanged expectation for fiscal 2023 interest expense in the mid $200. Looking beyond fiscal 2023, our strong continued progress on deleveraging and debt paydown support our expectation for our interest expense to steadily decline in the coming years, despite the rising interest rate environment. I will now hand it back to Sue to review our strategic progress in the quarter.